Dominic Snijders

Summary

Affiliation: Medical Centre Alkmaar
Country: The Netherlands

Publications

  1. ncbi D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial
    Dominic Snijders
    Department of Pulmonary Diseases, Medical Centre Alkmaar, Alkmaar, The Netherlands
    Eur J Intern Med 23:436-41. 2012
  2. ncbi Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial
    Dominic Snijders
    Department of Pulmonary Diseases, Medical Centre Alkmaar, Wilhelminalaan 15, 1812 JD Alkmaar, The Netherlands
    Am J Respir Crit Care Med 181:975-82. 2010
  3. ncbi Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
    Johannes M A Daniels
    Department of Pulmonary Diseases, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    Am J Respir Crit Care Med 181:150-7. 2010
  4. ncbi Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD
    Johannes M A Daniels
    Department of Pulmonary Diseases, Medical Centre Alkmaar, The Netherlands
    Chest 138:1108-15. 2010
  5. ncbi The influence of COPD on mortality and severity scoring in community-acquired pneumonia
    Dominic Snijders
    Department of Pulmonary Diseases, Medical Center Alkmaar, Alkmaar, The Netherlands
    Respiration 79:46-53. 2010

Detail Information

Publications5

  1. ncbi D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial
    Dominic Snijders
    Department of Pulmonary Diseases, Medical Centre Alkmaar, Alkmaar, The Netherlands
    Eur J Intern Med 23:436-41. 2012
    ..In this study we assess the use of D-dimer levels and its association with severity assessment and clinical outcome in patients hospitalised with community-acquired pneumonia...
  2. ncbi Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial
    Dominic Snijders
    Department of Pulmonary Diseases, Medical Centre Alkmaar, Wilhelminalaan 15, 1812 JD Alkmaar, The Netherlands
    Am J Respir Crit Care Med 181:975-82. 2010
    ..Some studies have shown a beneficial effect of corticosteroids in patients with community-acquired pneumonia (CAP), possibly by diminishing local and systemic antiinflammatory host response...
  3. ncbi Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
    Johannes M A Daniels
    Department of Pulmonary Diseases, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
    Am J Respir Crit Care Med 181:150-7. 2010
    ..The role of antibiotics in acute exacerbations is controversial and their efficacy when added to systemic corticosteroids is unknown...
  4. ncbi Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD
    Johannes M A Daniels
    Department of Pulmonary Diseases, Medical Centre Alkmaar, The Netherlands
    Chest 138:1108-15. 2010
    ..Rational prescription of antibiotics in acute exacerbations of COPD (AECOPD) requires predictive markers. We aimed to analyze whether markers of systemic inflammation can predict response to antibiotics in AECOPD...
  5. ncbi The influence of COPD on mortality and severity scoring in community-acquired pneumonia
    Dominic Snijders
    Department of Pulmonary Diseases, Medical Center Alkmaar, Alkmaar, The Netherlands
    Respiration 79:46-53. 2010
    ..Chronic obstructive lung disease (COPD) is a frequent co-morbidity in patients hospitalised with community-acquired pneumonia (CAP). In recent retrospective studies, higher mortality in patients with CAP and COPD was found...